{
    "id": "5e52c0c76d0a27794100004b",
    "question": "Is KAT2A involved in Acute myeloid leukemia (AML)?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine if KAT2A is involved in Acute myeloid leukemia (AML), we need to understand what KAT2A is and its potential role in cancer. KAT2A, also known as histone lysine demethylase 4 (KDM4), is an enzyme that removes methyl groups from histone proteins, which are essential for chromatin structure and gene regulation. Alterations in histone modifications, including demethylations, have been implicated in various cancers, including AML. Research has shown that KDM4A (a member of the KAT2A family) is overexpressed in some types of cancer, suggesting its potential role in tumorigenesis. Specifically, studies have found that KDM4A is involved in the regulation of genes that are critical for cell proliferation, differentiation, and survival, which are often disrupted in AML. Therefore, it is reasonable to conclude that KAT2A, through its enzymatic activity, may be involved in the pathogenesis of AML.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 11.11358380317688
}